Concepedia

Low-dose pioglitazone increases serum high molecular weight adiponectin and improves glycemic control in Japanese patients with poorly controlled type 2 diabetes

Yoshimasa Aso, Kenji Hara, Noriyuki Ozeki, Chikako Yatsuka, Tomoki Nakano, Sachiko Matsumoto, Mariko Suetsugu, Takafumi Nakamachi, Kohzo Takebayashi, Kohsuke Haruki,

Diabetes Research and Clinical Practice · 2009 · 27 citations · 20 references

DOI

Concepts

References

20

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

John Dormandy, B Charbonnel, D.J.A. Eckland et al. · The Lancet · 2005 · 4.1K citations · Full text

, , +15

Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy

Steven E. Kahn, Steven M. Haffner, Mark Heise et al. · New England Journal of Medicine · 2006 · 2.9K citations

, , +13

Structure-Function Studies of the Adipocyte-secreted Hormone Acrp30/Adiponectin

Utpal B. Pajvani, Xueliang Du, Terry P. Combs et al. · Journal of Biological Chemistry · 2003 · 1.1K citations · Full text

, , +16

Impaired Multimerization of Human Adiponectin Mutants Associated with Diabetes

Hironori Waki, Toshimasa Yamauchi, Junji Kamon et al. · Journal of Biological Chemistry · 2003 · 980 citations · Full text

, , +17

A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia

Ronald Goldberg, David M. Kendall, Mark A. Deeg et al. · Diabetes Care · 2005 · 795 citations · Full text

, , +14